The Patent Finder

Terms ending in 2026

Acclarent, Inc.

Every in-force patent on Acclarent, Inc.'s record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,399,121Systems and Methods for Transnasal Dilation of Passageways in the Ear, Nose or Throat
In force
 · High confidence
Acclarent, Inc.In forceHigh confidence
US 7,559,925Methods and Devices for Facilitating Visualization in a Surgical Environment
In force
 · High confidence
Acclarent Inc.In forceHigh confidence
US 9,089,258Endoscopic Methods and Devices for Transnasal Procedures
In force
 · High confidence
Acclarent Inc., a Delaware CorporationIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited